Article Information
History
- September 23, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Audrey D Zhang, Medical Student1,2,
- Jeremy Puthumana, Medical Student3,
- Nicholas S Downing, Associate4,
- Nilay D Shah, Associate Professor5,
- Harlan M Krumholz, Professor2,6,7 and
- Joseph S Ross, Professor2,7,8,*
- 1New York University School of Medicine, New York, NY, USA
- 2Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA
- 3Yale School of Medicine, New Haven, CT, USA
- 4Bain Capital, Boston, MA, USA
- 5Division of Health Care Policy and Research and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA
- 6Section of Cardiovascular Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven CT, USA
- 7Department of Health Policy and Management, Yale School of Public Health, New Haven CT, USA
- 8Section of General Medicine and the National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven CT, USA
- ↵*Corresponding Author:
Joseph S Ross, MD, MHS, Yale University School of Medicine, Section of General Internal Medicine, P.O. Box 208093, New Haven, CT 06520-8093, Phone: (203) 785-2987, Email: joseph.ross{at}yale.edu.
Posted September 23, 2019.
Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents Over Three Decades, 1995-2017: Cross-Sectional Analysis
